TransMedics Group, Inc.
TMDX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $35,464 | -$25,028 | -$36,231 | -$44,215 |
| Dep. & Amort. | $19,758 | $8,177 | $3,478 | $1,817 |
| Deferred Tax | $0 | -$1,660 | $0 | $0 |
| Stock-Based Comp. | $33,224 | $19,791 | $10,321 | $6,878 |
| Change in WC | -$45,000 | -$44,347 | -$26,759 | $3,003 |
| Other Non-Cash | $5,357 | $30,039 | $3,374 | $3,653 |
| Operating Cash Flow | $48,803 | -$13,028 | -$45,817 | -$28,864 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | -$151,847 | -$11,907 | -$3,519 |
| Net Acquisitions | $441 | -$14,894 | $107 | $0 |
| Inv. Purchases | $0 | $0 | -$10,496 | -$72,024 |
| Inv. Sales/Matur. | $0 | $0 | $76,916 | $104,810 |
| Other Inv. Act. | -$129,744 | -$27,212 | -$107 | $0 |
| Investing Cash Flow | -$129,303 | -$193,953 | $54,513 | $29,267 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $445,380 | $22,459 | $0 |
| Stock Issued | $22,874 | $0 | $139,854 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | -$44,962 | $5,614 | $1,393 |
| Financing Cash Flow | $22,874 | $400,418 | $167,927 | $1,393 |
| Forex Effect | -$536 | $193 | -$1,021 | -$797 |
| Net Chg. in Cash | -$58,162 | $193,630 | $175,602 | $999 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $395,312 | $201,682 | $26,080 | $25,081 |
| End Cash | $337,150 | $395,312 | $201,682 | $26,080 |
| Free Cash Flow | -$80,941 | -$192,087 | -$57,724 | -$32,383 |